PRESENTATION

Q1 2023 — Presentation

Q1 2023PDF · 37 pages1.4 MB
Presentation to Investors and Analysts
HSBC Holdings plc 1Q23 Results

-- 1 of 37 --

1
Appendix	1Q23 results
Summary of reporting changes from 1Q23
IFRS 17 insurance contracts
reporting Constant currency performance Secondary line of reporting by
main legal entity
 	We no longer recognise ‘significant
items’ in the reporting of our
business performance
 	Income and balance sheet numbers
in this presentation are on a
constant currency basis unless
stated otherwise
 	‘Notable items’ are disclosed
separately to highlight items
considered outside the normal
course of business and generally
non-recurring in nature
 	Our primary segmental reporting by
global business remains unchanged
 	Supplementary presentation of
results is now on a main legal entity
basis, replacing geographical
regions
 	On 1 st January 2023, the Group’s
treatment of insurance contracts
transitioned from IFRS 4 to IFRS 17
 	The impacts of IFRS 17 included a
$2.2bn reduction in NII and a $0.5bn
reduction in FY22 PBT. Further
impacts can be found on slide 30
and in our IFRS 17 transition
document1
 	This presentation is on an IFRS 17
basis unless noted otherwise. All
prior periods have been restated

-- 2 of 37 --

Strategic
progress
Noel Quinn
Group Chief Executive

-- 3 of 37 --

1Q23 results
update
Georges Elhedery
Group Chief Financial Officer

-- 4 of 37 --

4
Appendix	1Q23 results
Highlights
2 	$0.4bn ECL charge (18bps of gross loans & advances), reflecting improved economic assumptions
1 Reported PBT of $12.9bn. PBT up $9.0bn vs. 1Q22 on a constant currency basis, driven by an $8.6bn
increase in revenue. 1Q23 included $3.6bn of revenue notable items*
Dividend of $0.10 per share; the first quarterly dividend since 2019. Share buyback of up to $2bn planned
post AGM with an intention to complete this in around 3 months4	5
The remainder of the presentation unless otherwise stated, is presented on a constant currency basis
Figures throughout this presentation may be subject to rounding adjustments and therefore may not sum precisely to totals given in charts, tables or commentary
3 On a FY23 cost target basis (constant currency, excluding notable items, hyperinflation2 and additional costs
relating to SVB UK and related international investments), costs up $0.2bn (2%)
4 RoTE of 27.4%3; 19.3% if the provisional gain on acquisition of SVB UK and the part-reversal of France
impairment are excluded
* $2.1bn part-reversal of an impairment due to the accounting driven reclassification of the French retail business from held-for-sale and a $1.5bn provisional gain on the acquisition of SVB UK

-- 5 of 37 --

5
Appendix	1Q23 results
1Q23 results summary
$m 	1Q23 	1Q22 	Δ
NII 	8,959 	6,088 	47%
Non-NII 	11,212 	5,484 	>100%
o/w: notable items	
3,577 	(120) 	>100%
Revenue 	20,171 	11,572 	74%
ECL 	(432) 	(632) 	32%
Costs 	(7,586) 	(7,712) 	2%
Associates 	733 	610 	20%
Constant currency PBT 	12,886 	3,838 	>100%
FX translation 	— 	306 	—
Reported PBT 	12,886 	4,144 	>100%
Tax 	(1,860) 	(712) 	>100%
Profit attributable to ordinary shareholders 	10,327 	2,755 	>100%
Earnings per share, $ 	0.52 	0.14 	$0.38
Dividend per share, $ 	0.10 	— 	—
RoTE 3, % 	27.4 	7.2 	20.2ppts
$bn 	1Q23 	4Q22 	Δ
Customer loans 	963 	932 	3%
Customer deposits 	1,604 	1,583 	1%
Reported RWAs 	854 	840 	2%
CET1 ratio 5, % 	14.7 	14.2 	0.5ppts
TNAV per share, $ 	8.08 	7.44 	$0.64
 	NII of $9.0bn, up $2.9bn (47%), primarily due to interest rate rises.
Stable vs. 4Q22
 	Non-NII of $11.2bn, up $5.7bn includes:
 $3.6bn notable items which related to the accounting driven
reclassification of our French retail business from held-for-sale and
a provisional gain on acquisition of SVB UK
 $4.1bn trading income*, up $2.0bn
 	ECL charge of $0.4bn, reflecting improved economic assumptions
 	Costs of $7.6bn down $0.1bn (2%), primarily due to lower cost
notable items in the quarter. Up 2% in 1Q23 on a FY23 cost target
basis
 	Customer lending up $32bn vs. 4Q22 (3%), including $7.3bn loans
from SVB UK and $25bn of French retail loans reclassified from HFS.
Excluding these impacts, lending stable
 	Customer deposits up $21bn vs. 4Q22 (1%), including $8.5bn
deposits from SVB UK and $23bn of French retail deposits reclassified
from HFS. Excluding these impacts, deposits stable (down 0.6%)
 	$1.9bn tax charge included a $0.4bn uncertain tax provision release
in the UK
 	CET1 ratio of 14.7%, including a c.30bps gain relating to the part-
reversal of France impairment and our acquisition of SVB UK
 	TNAV per share of $8.08, up $0.64 vs. 4Q22 due to profit
generation
Variances on this slide are vs. 1Q22 if not otherwise stated
* Trading income reported in net income from financial instruments held for trading or managed on a fair value basis. This is partially offset at the total revenue level with a $1.4bn net interest expense for central costs of funding trading income

-- 6 of 37 --

6
Appendix	1Q23 results
226
1,934
1,875
(67)
1,927
1,476
283
200
649
616
(195)
499
8,599
(8)
o/w FX
+31
Revenue performance
1Q23 revenue 	1Q23 vs. 1Q22 	Revenue by global business, $bn
(0.4)
3.7
9.0
4.9
4.9
3.3
1Q22
4.4
3.4
(0.3)
6.9
4Q22
0.1
6.7
1Q23
20.2
11.6
14.8
+74%
including $3.6bn
notable items in 1Q23
WPB
Corporate
Centre
CMB
GBM
82%
99%
20%
of which: GPS
GPS
GTRF
Credit and Lending
Other
Wealth
Other
$8,983m
$6,675m
$4,440m
$73m
$20,171m 	74%
$1,961m
$306m
$1,075m
$2,558m
$1,890m
$2,911m
$1,364m
$510m
$2,055m
MSS
WPB
CMB
GBM
Corp. Centre
Group
Banking
$1,219m
Other 	$(250)m
Personal Banking 	$4,967m
of which: Capital
Markets & Advisory
$2,132m
of which: FX
13%
64%
>100%
(2)%
(5)%
>100%
>100%
12%
20%
44%
>100%
11%
>(100)%
o/w SVB UK
gain $1,511m
o/w: France impairment
reversal $2,021m*
* A further $0.1bn relating to the impairment part-reversal is booked in Corporate Centre

-- 7 of 37 --

7
Appendix	1Q23 results
2,201 	2,149 	2,110 	2,116 	2,153
169bps	168bps
119bps 	129bps 151bps
+1bp
Net interest income and margin
 Reported NII of $9.0bn, up $2.5bn vs. 1Q22
(38%) and stable vs. 4Q22, despite a lower day
count
 NIM up 2bps on a constant currency basis
(4Q22 constant currency: 1.67%)
 Reported NII included $1.4bn interest expense for
centrally allocated funding costs associated with
funding GBM’s trading activities (4Q22: $1.4bn;
1Q22 $0.1bn). This was offset by $1.4bn reported
in Corporate Centre trading income
 NII guidance assumes this expense will be around
the annualised 4Q22/1Q23 run-rate
 NIM of 1.69%, up 1bp vs. 4Q22 on a reported
basis. Benefit from higher rates was partly offset by
continued deposit migration in Asia (HBAP)
 FY23 NII guidance is unchanged (≥$34bn when
recomputed for IFRS 17)
Reported NIM trend
Discrete quarterly
NIM
Average interest earning
assets (AIEAs), $bn:
8,986
8,006
4Q22	3Q22	1Q22 	2Q22 	1Q23
6,475 6,910
8,959
NIM progression, bps
168 	169	64
1Q23	4Q22 	Asset yields
(63)
Liability costs
Reported NII, $m
(0.1) 	(0.3) 	(0.8) 	(1.3) 	(1.4)
Central costs of funding
trading income, $bn 6:

-- 8 of 37 --

8
Appendix	1Q23 results
Non-NII
Group non-NII, $m
3.1
4Q22
0.3
2.1
1Q23
2.7
1Q22
2.7
0.4
3.0
4.1
0.5
3.6
5.5 5.8
11.2
Other income
Gain on acquisition of
SVB UK and France
impairment reversal
Net fees
Net income from
financial instruments
held for trading
or managed on
a fair value basis
 Non-NII up $5.7bn vs. 1Q22, primarily due to:
 	Notable items of $3.6bn ($2.1bn part-reversal of France
impairment and $1.5bn provisional gain on acquisition of SVB UK)
 	Higher income from trading and fair value instruments of
$4.1bn, up $2.0bn. This income was partially funded by the
$1.4bn interest expense representing central costs of funding
GBM trading activity detailed on slide 7. This was up $1.3bn vs.
$0.1bn in 1Q22
 	Other income of $0.5bn, up $0.2bn vs. 1Q22, including higher
income in Wealth. NNIA in the last 12 months of $93bn, including
$22bn during the quarter
 Fees broadly stable vs. 1Q22. GPS fees of $0.5bn, up 9%
 Detailed non-NII breakdown by business on slide 17
o/w
notables
$0.1bn
o/w
notables
$0.3bn

-- 9 of 37 --

9
Appendix	1Q23 results
0.25 	0.17 	0.41 	0.56 	0.17
Credit performance
ECL charge trend, $m
ECL charge as a
% of average
gross loans and
advances 7
ECL charge by stage, $bn	ECL charge / (release) by entity, $m
632 430
1,083
1,455
432
1Q23	4Q22	3Q22	2Q22	1Q22
ECL
Stage 1-2 	Stage 3 	Total
Wholesale 	(0.1) 	0.3 	0.2
Personal 	0.1 	0.2 	0.2‡
Total 	0.0 	0.4‡ 0.4
1Q23 	4Q22
Asia (HBAP) 	67 	904
o/w Hong Kong	
44	
764
UK RFB (HBUK) 	161 245
HSBC Bank plc (HBEU) 	18 	59
USA (HNAH) 	29 	(1)
Canada (HBCA) 	1 	20
Mexico (HBMX) 	128 	183
HSBC Middle East (HBME) 	(7) 	37
Other8 	35 	8
Total 	432 	1,455
 	$0.4bn charge includes a minimal stage 1-
2 charge, reflecting improved economic
assumptions
 	$62m mainland China CRE charge
related to credit quality adjustments for two
customers. There were no defaults during
the quarter though there were also limited
repayments
 	Stage 3 balances of $20bn, stable vs. 4Q22
 	FY23 ECL guidance unchanged at
~40bps7
* Mainland China CRE charge is on a reported basis and has not been currency adjusted in prior periods
‡ Totals do not sum due to rounding
 Includes a stage 1 provision on acquisition of SVB UK of GBP £22.2m
Mainland China
CRE charge, $m*
196 	151 	363 	598 	62

-- 10 of 37 --

10
Appendix	1Q23 results
(2)%
1Q23
1,200
3Q22
420
7,751
4Q22	1Q22
704
2Q22
8,958
576 	61
7,712 	7,864 	7,586
(15)%
7,356
6,926 	6,926
Costs
Operating expenses trend, $m
1Q23 vs. 1Q22 (constant currency), $m
 	1Q23 constant currency costs of $7.6bn, down
$0.1bn (2%) vs. 1Q22 due to the end of the CTA
programme and the flow through of cost savings
into FY23
 	Targeting c.3% cost growth in FY23 vs. a FY22
cost target base of $29.6bn9 (reconciliation on slide
30). Costs associated with SVB UK and related
international investments are expected to increase
costs by a further c.1% ‡. On this basis:
 1Q23 costs of $7.5bn, up $0.2bn (2%) vs. 1Q22,
due to a higher spend on technology
 2Q23 expected to be impacted by c.$0.3bn
severance costs (included in 3% target)
270
(21)
7,712
1Q22 	Marketing,
T&E, PRP
(359)
Notable items
(primarily CTA)
(16)
Tech
spend
Other*
7,586
1Q23
(2)%
o/w notable items (FX adjusted)
* Other includes increased investment in wealth in Asia, inflationary impacts and higher costs associated with volume growth. These were offset by flow through cost savings from the CTA programme
‡ The acquisition of SVB UK is expected to increase revenue by c.$0.4bn in FY23

-- 11 of 37 --

11
Appendix	1Q23 results
Customer deposits
High quality liquid assets (HQLA)*, $bn
Deposits by global business, $bn
Central &
local
government
bonds
343
Other
39
Cash and
cash
equivalents
444
$826bn
HQLA
 	$1.6tn deposits, stable vs. 4Q22
 	Group HQLA is equivalent to 51% of customer
deposits
 	Cash and cash equivalents makes up over
40% of our HQLA with the vast majority of the
remainder driven by held-to-collect-and-sell
securities (HTC&S)
 	Unrealised losses in our HTC portfolio of
$1.4bn, down from $1.9bn at FY2210
GBM
810 WPB
322
1
471
CMB
Other
$1,604bn
deposits
1,583 	1,604
1Q22 	4Q22 	1Q23
1,655
Customer deposits trend, $bn
Customer deposits by key legal entity
49%
21%
18% 	Asia (HBAP)
6%
UK RFB
HSBC Bank
Plc
USA (HNAH) Other
6%
* HQLA is the period end value before the application of the Group adjustment for restrictions on the transfer of entity liquidity around the Group. On a 12-month average basis for FY22 this was $812bn
1Q23 HQLA shown on this slide differs from the earnings release, which is a 12 month average after the impact of the above adjustment

-- 12 of 37 --

12
Appendix	1Q23 results
 	CET1 ratio of 14.7%, up 0.5ppts vs. 4Q22, driven by
profit generation and includes a 0.25ppts impact from the
part-reversal of France impairment
 	CET1 capital increased by $6.4bn
 	RWAs up $14.7bn, largely due to $9.6bn SVB UK RWAs
and asset growth in sovereign exposures and retail
lending. This was partially offset by a $7.7bn reduction in
RWAs from a regulatory change in Hong Kong which
reduced the risk weighting of residential mortgages
 	Our banking business in Canada remains in held-for-
sale. The transaction is now expected to complete in 1Q24
to ensure a smooth transition
 	We remain committed to consider the payment of a
$0.21 per share special dividend as a priority use of
proceeds, to be paid in 1H24
 	The remaining proceeds will accrue in CET1 capital
and we intend to use excess capital to supplement
future share buyback programmes
 	We anticipate the share buyback of up to $2bn to impact
the CET1 ratio by c.25bps in 2Q23
 	First quarterly dividend since 2019 of $0.10 per share
Capital adequacy
1Q23 	4Q22 	1Q22
Common equity tier 1 capital, $bn 	126 	119 	121
Risk-weighted assets, $bn 	854 	840 	862
CET1 ratio, % 	14.7 	14.2 	14.1
Leverage exposure, $bn 	2,486 	2,417 	2,533
Leverage ratio, % 	5.8 	5.8 	5.7
Capital progression5
CET1 ratio, %11
1.0
0.3
0.0
SVB UK	4Q22 	1Q23
(0.2)
Profits12 	Dividend
accrual 13
14.2
Change
in
RWAs
FX
translation
differences
France
impairment
reversal
Other
(0.5) (0.1)
0.0* 	14.7
119.3
839.7
125.7	CET1, $bn
RWAs, $bn 	854.4	3.4
0.6	(3.9)
1.7
(1.3)	7.6 	1.5 	1.9
9.6
* Increases the CET1 ratio by c.5bps

-- 13 of 37 --

13
Appendix	1Q23 results
Summary
2 	$9bn NII, stable vs. 4Q22, supported by our core global deposit franchises
1 	Strong quarter with PBT of $12.9bn, including the effect of $3.6bn of revenue notable items
5 Strong capital distributions: returned to a quarterly dividend of $0.10 per share; up to $2bn share
buyback planned post AGM, intention to complete in around 3 months 4. Outlook positive for future
distributions, including Canada proceeds
4 	Low ECL charge reflecting a benign credit environment
3 	Continued cost discipline with costs up 2% vs. 1Q22, relative to the FY23 3% cost target

-- 14 of 37 --

Appendix

-- 15 of 37 --

15
Appendix	1Q23 results
Group guidance summary
Capital and
distributions
Guidance (to be reviewed at 1H23)
CET1
Dividends
Manage in 14-14.5% target range in the medium term; aim to manage range down further longer term
Dividend payout ratio of 50% for 2023 and 202416
Lending 	Cautious outlook on loan growth in the short term; expect mid-single digit percentage annual loan growth in the medium to long term
ECL 	FY23 ECL charge of around 40bps 7 ; through-the-cycle planning range of 30-40bps
Asia as a % of Group TE14 	c.50% medium to long term15
NII 	FY23 NII ≥$34bn on an IFRS 17 basis
RoTE 	Targeting 12%+ from FY23
Costs Approximately 3% cost growth in FY23 vs. a FY22 cost target base of $29.6bn9 (constant currency, excluding notable items, hyperinflation2 and
c.1% additional cost growth from our SVB UK acquisition and related international investments). Full reconciliation on slide 30

-- 16 of 37 --

16
Appendix	1Q23 results
Key financial metrics
Reported results, $m 	1Q23 	4Q22 	1Q22
NII 	8,959 	8,986 	6,475
Other Income 	11,212 	5,581 	5,830
Revenue 	20,171 	14,567 	12,305
ECL 	(432) 	(1,430) 	(639)
Costs 	(7,586) 	(8,781) 	(8,178)
Associate income 	733 	693 	656
Profit before tax 	12,886 	5,049 	4,144
Tax 	(1,860) 	(388) 	(712)
Profit after tax 	11,026 	4,661 	3,432
Profit attributable to ordinary shareholders (‘PAOS’) 	10,327 	4,378 	2,755
Basic EPS, $ 	0.52 	0.22 	0.14
Diluted EPS, $ 	0.52 	0.22 	0.14
DPS (in respect of the period), $ 	0.10 	0.23 	—
Net interest margin (annualised), % 	1.69 	1.68 	1.19
Alternative performance measures, $m 	1Q23 	4Q22 	1Q22
Constant currency NII 	8,959 	9,086 	6,088
Constant currency other income 	11,212 	5,757 	5,484
Constant currency revenue 	20,171 	14,843 	11,572
Constant currency ECL 	(432) 	(1,455) 	(632)
Constant currency costs 	(7,586) 	(8,958) 	(7,712)
Constant currency associate income 	733 	716 	610
Constant currency profit before tax 	12,886 	5,146 	3,838
PAOS excl. goodwill and other intangible impairment 	10,345 	4,433 	2,759
Return on average tangible equity (annualised), % 	27.4 	12.3 	7.2
Return on average equity (annualised), % 	25.5 	11.3 	6.7
Constant currency net loans and advances to customers, $bn 	963 	932 	1,018
Constant currency customer accounts, $bn 	1,604 	1,583 	1,655
Cost efficiency ratio, % 	38 	60 	67
ECL charge as a % of average gross loans and advances to
customers, annualised
(including held-for-sale balances) 0.18
(0.17) 0.59
(0.56) 0.25
(0.25)
Reported balance sheet, $bn 	1Q23 	4Q22 	1Q22
Total assets 	2,990 	2,949 	3,012
Net loans and advances to customers 	963 	924 	1,054
Customer accounts 	1,604 	1,570 	1,710
Quarterly average interest-earning assets 	2,153 	2,116 	2,201
Reported loan/deposit ratio, % 	60.1 	58.8 	61.7
Ordinary shareholders’ equity (NAV) 	171 	158 	165
Tangible ordinary shareholders’ equity (TNAV) 	159 	147 	154
NAV per share, $ 	8.65 	8.01 	8.25
TNAV per share, $ 	8.08 	7.44 	7.70
Capital, leverage and liquidity5 	1Q23 	4Q22 	1Q22
Risk-weighted assets, $bn 	854 	840 	862
CET1 ratio, % 	14.7 	14.2 	14.1
Total capital ratio (transitional), % 	19.8 	19.3 	19.2
Leverage ratio, % 	5.8 	5.8 	5.7
High-quality liquid assets (liquidity value), $bn* 	635 	647 	688
Liquidity coverage ratio, % 	132 	132 	137
Share count, m 	1Q23 	4Q22 	1Q22
Basic number of ordinary shares outstanding 	19,736 	19,739 	19,968
Basic number of ordinary shares outstanding and dilutive
potential ordinary shares 19,903 	19,878 	20,134
Quarterly average basic number of ordinary shares outstanding 	19,724 	19,738 	20,024
* HQLA shown is after the application of an adjustment to reflect the restrictions on the transfer of entity liquidity around the Group. HQLA before the application of this adjustment is $826bn as at 1Q23

-- 17 of 37 --

17
Appendix	1Q23 results
Non-NII by business
$m 	Fees 	Other 	Total 	Fees 	Other 	Total 	Fees 	Other 	Total
Personal Banking 	293 	15 	308 	316 	10 	326 	298 	13 	311
Wealth Management 	1,003 	580 	1,583 	891 	507 	1,398 	1,054 	414 	1,468
o/w Life insurance	
41	
343	
384	
31	
311	
342	
43	
254	
297
Other 	19 	2,082* 	2,101 	36 	49 	85 	30 	109 	139
Total 	1,315 	2,677 	3,992 	1,243 	566 	1,809 	1,382 	536 	1,918
Global Trade & Receivables Finance (GTRF) 	262 	4 	266 	228 	3 	231 	257 	5 	262
Credit & Lending 	185 	4 	189 	169 	(11) 	158 	182 	12 	194
Global Payments Solutions (GPS) 	359 	3 	362 	356 	0 	356 	316 	1 	317
Other 	180 	1,711‡ 1,891 	146 	143 	289 	201 	147 	348
Total 	986 	1,722 	2,708 	899 	135 	1,034 	956 	165 	1,121
Markets & Securities Services 	105 	2,324 	2,429 	71 	1,795 	1,866 	195 	1,959 	2,154
Banking 	624 	(16) 	608 	528 	(77) 	451 	627 	31 	658
o/w GPS	
161	
1	
162	
167	
1	
168	
159	
0	
159
o/w Cap. Markets & Advisory	
179	
2	
181	
108	
6	
114	
170	
7	
177
Other 	(19) 	(99) 	(118) 	7 	(414) 	(407) 	(62) 	5 	(57)
Total 	710 	2,209 	2,919 	606 	1,304 	1,910 	760 	1,995 	2,755
Memo item: total GPS non-NII	
520	
4	
524	
523	
1	
524	
475	
1	
476
Memo item: total GTRF non-NII	
373	
4	
377	
334	
4	
338	
363	
5	
368
WPB
1Q23
CMB
GBM
4Q22 	1Q22
* Inclusive of $2,021m part-reversal of impairment relating to planned sale of French retail business
‡ Inclusive of $1,511m provisional gain on acquisition of SVB UK

-- 18 of 37 --

18
Appendix	1Q23 results
Financial investments
Debt financial investments revaluation movements*, $bn
 	Our Treasury debt securities portfolio has minimal unrealised
losses in the hold-to-collect (‘HTC’) book. Excluding holdings for
our insurance business which have been primarily reclassified out
of HTC under IFRS 17, unrealised losses have fallen to $1.4bn as
rates have declined 10
 	Mark-to-market moves in our hold-to-collect and sell (‘HTC&S’)
book are taken directly through equity (via other comprehensive
income) and CET1 as they materialise. These losses have fallen to
$5.9bn
 	Risk reduction measures have lowered the HTC&S stressed
value at risk exposure of this portfolio from $3.6bn at the end of
2021 to $2.2bn at the end of 2022
4Q22 Change in
quarter 1Q23
Hold-to-collect (‘HTC’) 	(1.9) 	0.5 	(1.4)
Hold-to-collect and sell (‘HTC&S’) 	(6.5) 	0.6 	(5.9)
* Excludes insurance

-- 19 of 37 --

19
Appendix	1Q23 results
Notable items (reported basis)
$m 	1Q23 	4Q22 	3Q22 	2Q22 	1Q22
Revenue 	3,577 	(320) 	(2,691) 	(471) 	(120)
o/w: Disposals, acquisitions and related costs	
3,562	
(71) 	(2,378)	
(288)	
—
o/w: Fair value movements on financial instruments	
15	
35	
(282)	
(171)	
(200)
o/w: Restructuring and other related costs	
—	
(284)	
(31)	
(12)	
80
Costs 	(61) 	(1,169) 	(691) 	(589) 	(451)
o/w: Disposals, acquisitions and related costs 	(61)	
(9)	
(9)	
—	
—
o/w: Restructuring and other related costs	
— 	(1,160)	
(682)	
(589)	
(451)
Total 	3,516 	(1,489) 	(3,382) 	(1,060) 	(571)
3
Memo: in 1Q23 there was a release of a $0.4bn uncertain tax provision relating to the UK

-- 20 of 37 --

20
Appendix	1Q23 results
NII/NIM supplementary information
1Q22 	2Q22 	3Q22 	4Q22 	1Q23 % of 1Q23
Group NII
% of 1Q23
Group AIEA
The Hongkong and
Shanghai Banking
Corporation (HBAP)
1.24% 	1.32% 	1.66% 	1.94% 	1.83% 	47% 	43%
HSBC Bank plc 	0.55% 	0.57% 	0.44% 	0.50% 	0.59% 	8% 	22%
HSBC UK Bank plc (UK
RFB) 1.63% 	1.77% 	1.99% 	2.19% 	2.33% 	25% 	18%
HSBC North America
Holdings, Inc 0.90% 	1.05% 	1.16% 	1.16% 	1.15% 	5% 	8%
Quarterly NIM by key legal entity
Key rates (quarter averages), bps
20 	31
164
368 303 	299
12 77
219
392 452 	483
45 95 162
283
385 425
2Q23 QTD*	1Q23	2Q22	1Q22 	3Q22 	4Q22
1M HIBOR 	Fed effective rate 	BoE Bank rate
Source: Bloomberg
* At 28 April 2023
 	We continue to further reduce NII sensitivity to downside interest rate risk through
increased hedging 	 	Under IFRS 4, FY22 insurance NII was $2.6bn. Following the
implementation of IFRS 17 and the reclassification of assets
backing policyholder liabilities, insurance NII has fallen to
c.$0.1bn per quarter, primarily NII on shareholder assets
 	FY22 insurance AIEAs under IFRS 4 were $73bn and were
$19bn at 1Q23 under IFRS 17
Reported NII trend IFRS 4 and IFRS 17, $bn
1Q22 	2Q22 	3Q22 	4Q22 	1Q23
IFRS 4 NII 	7.0 	7.5 	8.6 	9.6 	—
o/w insurance	
0.6	
0.6	
0.7	
0.7 	—
IFRS 17 NII 	6.5 	6.9 	8.0 	9.0 	9.0
o/w insurance	
0.1	
0.1	
0.1	
0.1	
0.1

-- 21 of 37 --

21
Appendix	1Q23 results
+82%
1Q23 financial highlights
Revenue 	$9.0bn 82%
(1Q22: $4.9bn)
ECL 	$(0.2)bn 27%
(1Q22: $(0.3)bn)
Costs 	$(3.5)bn 1%
(1Q22: $(3.5)bn)
PBT 	$5.3bn >100%
(1Q22: $1.1bn)
RoTE *, 17 	50.2% 39.9ppts
(1Q22: 10.3%)
1,735 	1,774 	1,794 	1,961
3,033 	3,418 	4,314 	5,069 	4,967
(2,388)
3Q22
6,932
2Q22
180
1,637
1Q22
(4)
197 69
4Q22
2,021
34
1Q23
4,948 	5,051 3,897
8,983
+30%
Wealth and Personal Banking
Wealth Management
Personal Banking
Other
France disposal
Reported Wealth Balances, $bn
1Q23 vs. 1Q22
 Revenue up $4.0bn (82%), of which $2.0bn relates to the France
impairment part-reversal. Personal Banking up $1.9bn (64%)
primarily due to rate rises and balance sheet growth in the UK RFB,
HBAP, Mexico and the Middle East. Wealth up $226m due to higher
Private Banking, Insurance and Asset Management revenue
 Customer lending and accounts were each down 3% due to HFS
transfers. Excluding the impact of HFS:
 Lending up $13bn (3%) including mortgage growth of $11bn
($7bn UK, $3bn HBAP) and unsecured lending growth of $4bn
($2bn HBAP, $1bn Mexico), partially offset by the closure of the
John Lewis portfolio ($1bn)
 Deposits up $7bn (1%) with growth particularly in HBAP, Mexico
and the Middle East
 Wealth balances down 2%. Excl. HFS impact, balances remain
stable. NNIA of $93bn since 1Q22 and wealth deposit growth of
$7bn was offset by lower market levels and adverse FX impacts of
$89bn
1Q23 vs. 4Q22
 Revenue up $2.1bn (of which $2.0bn France impairment part-
reversal). Personal Banking down $0.1bn (2%), primarily due to
term deposit migration in Asia. Wealth up $0.2bn with higher
mutual fund sales in investment distribution and Private Banking
 Customer lending and accounts excl. impact of HFS remain
broadly stable
 Wealth balances up 5%. Excl. HFS impact, up $58bn (4%) due to
NNIA of $22bn, wealth deposit growth of $4bn and higher market
levels and favourable FX impacts of $32bn
Revenue performance, $m
HFS
Portfolio18
Balance sheet, $bn
1Q22 	4Q22 	1Q23
Customer lending
Customer accounts
837
784 	810
841
57 	34
844
1,082 	1,015 	1,074
557 503 526
1Q22
1,639
73 50
4Q22 	1Q23
1,591 1,650
Wealth deposits 19
Invested assets
HFS
Portfolio18
469
427 	455
53 	27
480 	482
* RoTE (annualised) in 1Q23 included a 21.3 percentage point favourable impact of the part-reversal of the impairment losses relating to the planned sale of our retail banking operations in France

-- 22 of 37 --

22
Appendix	1Q23 results
+99%
Commercial Banking
Balance sheet, $bn
Customer lending
Customer accounts
Revenue performance, $m
GPS
Markets products, Insurance
and Investments and Other
Credit & Lending
GTRF
414
518
984
4,413
533
1,349
1Q22
322
3,347
4Q22	2Q22
478
1,443
1,963
3Q22
276
507
1,396
2,677
1,890‡
510
1,364
4,856
2,911
6,675
1Q23
1,463
1,431
529
3,666
+37%
1Q23 financial highlights
Revenue 	$6.7bn 99%
(1Q22: $3.3bn)
ECL 	$(0.2)bn >(100)%
(1Q22: $0.0bn)
Costs 	$(1.7)bn (2)%
(1Q22: $(1.7)bn)
PBT 	$4.8bn >100%
(1Q22: $1.7bn)
RoTE *, 17 	36.1% 24.1ppts
(1Q22: 12.0%)
1Q23 vs. 1Q22
 Revenue up $3.3bn (99%) with double digit growth across all
our main legal entities, notably in the UK RFB and Asia. The key
drivers were a $1.9bn increase in GPS due to interest rates and
fee growth and a $1.5bn provisional gain on the SVB UK
acquisition. This was partly offset by lower Credit & Lending due
to higher funding costs, notably in HBAP and HSBC Bank plc
 Customer lending and accounts of $323bn and $471bn were
down 7% and 3% respectively due to Canada HFS transfer, partly
offset by the SVB UK acquisition. Excluding these:
 Lending down $4bn (1%), mainly driven by reductions in Hong
Kong, partly offset by a transfer of GBM clients into CMB in
Australia and Indonesia
 Deposits down $3bn (1%), driven by market wide reductions
in the UK, partly offset by growth in HBAP outside Hong Kong
1Q23 vs. 4Q22
 Revenue up $1.8bn (37%). Growth was largely in our main legal
entities in the UK, Asia and Europe and was driven by the $1.5bn
provisional gain on the SVB UK acquisition, higher GPS revenue
and higher fees across all products
 Customer lending and accounts are up 3% and up 1%
respectively. Excluding SVB UK balances:
 Lending broadly stable
 Deposits down $6bn (1%) with reductions in the UK RFB and
HSBC Bank plc, mainly reflecting seasonal trends
488
468 	471
490
4Q22	1Q22
22 	22
493
1Q23
346
315 	323
1Q23	1Q22
26	25
4Q22
340 	349
o/w: HFS portfolio20
o/w
SVB UK
$7bn
o/w
SVB UK
$8bn
* RoTE (annualised) in 1Q23 included a 13.3 percentage point favourable impact of the provisional gain on the acquisition of SVB UK
‡ o/w $1.5bn provisional gain on acquisition of SVB UK

-- 23 of 37 --

23
Appendix	1Q23 results
Global Banking and Markets
Management view of revenue
Key indicators
2,275 	2,375 	2,304 	1,955 2,558
1,483 	1,610 	1,711 1,940
2,132
(491)	(215)
3Q22
(55) 	(248)
1Q22 	2Q22
3,404
4Q22
(250)
1Q23
3,703 3,737 	3,800
4,440
+20% 	+30%
MSS 	Other	Banking
Revenue performance, $m
$m 	1Q23 	∆1Q22
MSS 	2,558 	12%
Securities Services 	585 	27%
Global Debt Markets 	350 	78%
Global FX 	1,219 	20%
Equities 	143 	(64)%
Securities Financing 	261 	24%
XVAs 	0 	100%
Banking 	2,132 	44%
GTRF 	179 	9%
GPS 	1,075 	>100%
Credit & Lending 	498 	(8)%
Capital Markets &
Advisory 306 	11%
Other 	74 	76%
GBM Other 	(250) >(100)%
Principal Investments 	(4) >(100)%
Other 	(246) >(100)%
Net operating
income 4,440 	20%
1Q23 financial highlights
Revenue 	$4.4bn 20%
(1Q22: $3.7bn)
ECL 	$(0.0)bn 89%
(1Q22: $(0.3)bn)
Costs 	$(2.4)bn 2%
(1Q22: $(2.3)bn)
PBT 	$2.0bn 86%
(1Q22: $1.1bn)
RoTE 17 	15.5% 6.8ppts
(1Q22: 8.7%)
1Q23 vs. 1Q22
 Revenue of $4.4bn, up $0.7bn (20%)
 MSS revenue of $2.6bn, up $0.3bn (12%):
 Global Debt Markets up 78% vs. 1Q22 due to a strong trading
performance and the challenging market conditions in 1Q22
 Global FX up due to client hedging activity driven by inflation
and interest rate expectations
 Equities down due to reduced volatility which resulted in lower
client volumes, largely in derivatives
 Securities Services up 27% due to interest rate rises, partially
offset by reduced fees from lower market levels
 Banking revenue of $2.1bn, up $0.6bn (44%):
 GPS up >100% due to higher interest rates
 Capital Markets, which includes Issuer Services, up marginally
year on year
 Credit and Lending down 8% largely due to continued balance
sheet discipline
1Q23 vs. 4Q22
 Revenue up $1.0bn (30%):
 Higher Global FX related to client activity and trading
performance
 Global Debt Markets, up >100%, due to client activity across
primary and secondary markets
 Capital Markets and Advisory up >100% due to higher investor
and issuer demand for most of the quarter
1Q23 ∆1Q22
Cost-income ratio, % 	53 	(9)ppts
Gross Capital Markets and
Advisory revenue 21, $m 483 	4%
Customer lending 22, $bn 	184 	(9)%
Customer deposits, $bn* 	322 	(2)%
Assets under custody, $tn 	8.7 	(8)%
RWAs, $bn 	225 	(2)%
* Between 4Q22 and 1Q23, $4.3bn deposits were transferred from GBM to CMB in Australia and Indonesia. At 1Q23, $4.9bn GBM balances were in held-for-sale relating to Canada

-- 24 of 37 --

24
Appendix	1Q23 results
1Q23 financial highlights
Revenue 	$73m >100%
(1Q22: $(426)m)
ECL 	$(3)m (50)%
(1Q22: $(2)m)
Costs 	$(23)m 89%
(1Q22: $(206)m)
Associates 	$716m 19%
(1Q22: $602m)
PBT 	$763m >100%
(1Q22: $(32)m)
RoTE 17 	11.1% 13.0ppts
(1Q22: (1.9)%)
Corporate Centre
Revenue performance, $m
624 	649 478 578 	650
93
133 110
1
(2)
119
(20)
1Q22 	2Q22
769
(3)
1Q23	3Q22
(1)
4Q22
(44)
602 568
710 716
+1%
Associate income detail, $m
1Q22 	2Q22 	3Q22 	4Q22 	1Q23
Central Treasury 	(189) 	(189) 	(352) 	(12) 	101
Legacy Portfolios 	(19) 	24 	(7) 	(170) 	(2)
Other 	(218) 	(349) 	(240) 	(167) 	(26)
Total 	(426) 	(514) 	(599) 	(349) 	73
Not included in Corporate Centre revenue: Markets
Treasury revenue allocated to global businesses 472 	354 	349 	298 	243
BoCom 	Saudi Awwal Bank (SAB) 	Others
1Q23 vs. 4Q22
 Revenue up $422m, primarily due to the non-recurrence of
disposal losses on legacy portfolios, favourable valuation
differences in 1Q23 and transactional FX-related valuation gains
 RWAs up $6bn (7%), including on FX hedges related to the
planned sale of our banking business in Canada and higher
structural FX RWAs
1Q23 vs. 1Q22
 Revenue up $499m, primarily in Central Treasury reflecting the
non-recurrence of adverse FV movements on non-qualifying
hedges in 1Q22, partly offset by adverse FV moves on FX hedges
relating to the planned sale of our Canada business
 RWAs up $6bn (7%), including on FX hedges related to the
planned sale of our banking business in Canada, partly offset by
lower structural FX RWAs
RWAs, $bn
51 	51 	52
38 	38 43
1Q22 	4Q22 	1Q23
89 	89 95
+7% 	+7%
Associates 	Other

-- 25 of 37 --

25
Appendix	1Q23 results
Wealth and insurance
 	1Q23 revenue was up 14% on 1Q22 with improvements in CSM release
and positive market conditions benefiting the net investment margin
 	New business CSM in 1Q23 of $0.4bn was up $0.1bn vs. 1Q22 due to
the opening of the border between mainland China and Hong Kong and
new product launches. ANP of $0.9bn was up $0.2bn (35%)
Asia (HBAP)	Global
143
46	25
141
1Q22
292 	284
4Q22
72
150
275
1Q23
460 	470 497
+8%
338
1,047
31
322
1,099
4Q22
422
1Q22
340
312
363
25
376
335
363
1Q23
1,082
+2%
 Global reported invested assets stable vs. 1Q22. Up 2% excluding the impact of
held-for sale balances, driven by $93bn NNIA over the last 12 months ($22bn in
1Q23) which offset the lower market levels and adverse FX impact ($76bn)
 HBAP reported invested assets grew by 8% vs. 1Q22 driven by $66bn NNIA over
the last 12 months ($14bn in 1Q23) which offset the lower market levels ($29bn)
Retail 	GPB 	AM 3rd party distribution & pension 	HFS
1,735 	1,637 	1,774 	1,794 	1,961
1Q23	1Q22 	4Q22	2Q22 	3Q22
+13%
Wealth revenue, $m
Life insurance reported income statement, $m
1H22 	2H22 	FY22
Revenue 	659 	697 	1,356
ECL 	(4) 	(5) 	(9)
Operating expenses 	(363) 	(401) 	(764)
Associates 	4 	14 	18
PBT 	296 	305 	601
Quarterly reported life insurance revenue: 1Q22 $392m; 2Q22 $267m; 3Q22
$278m; 4Q22 $419m; 1Q23 $448m
Reported invested assets, $bn

-- 26 of 37 --

26
Appendix	1Q23 results
Balance sheet – customer lending
346
469
0	0
315
202
932
1Q22
427
0
190
4Q22
455
323
184
1Q23
WPB
CMB
GBM
1,018 963
Balances by global business, $bn
 	Customer lending of $963bn up $32bn
(3%) vs 4Q22. Excluding the reclassification
of French retail balances from HFS and
balances acquired from SVB UK, lending
stable
 	WPB up $28bn (7%), primarily due to
$25bn of French retail balances being
reclassified from held for sale
 	CMB up $8bn (3%), mainly due to $7bn
balances from SVB UK. Excluding this,
lending was broadly stable
 	GBM down $6bn (3%), reflecting $4bn
loans moved to CMB in Australia and
Indonesia
Balances by entity
$(2)bn
(1)%
$7bn
$25bn
$(3)bn
(1)%
$6bn
2%
$29bn
33%
$1bn
3%
$0bn
0%
$(1)bn
(5)%
$(0)bn
(0)%
$32bn
3%
$469bn
$259bn
$54bn
$19bn
$963bn
$291bn
$118bn
$23bn
$22bn
Growth since 4Q22
Asia (HBAP)
UK RFB (HBUK)
USA (HNAH)
Mexico (HBMX)
Other 8
HSBC Bank plc
(HBEU)
o/w: Hong
Kong
HSBC Middle
East (HBME)
Total
o/w:
France
retail
o/w: SVB UK
81
0
56
1,013 	1,019
HFS

-- 27 of 37 --

27
Appendix	1Q23 results
Balance sheet – customer accounts
Balances by global business, $bn
 Customer accounts of $1,604bn, up
$21bn (1%) vs 4Q22. Excluding the
reclassification of France balances from HFS
and balances from SVB UK, stable (down
0.6%) as clients have reduced excess
balances
 WPB up $25bn (3%) primarily due to $23bn
of French retail balances being reclassified
from held for sale
 CMB up $3bn (1%), mainly due to SVB UK
acquisition23. Excluding this, balances down
$6bn, mainly reflecting seasonal trends in the
UK RFB and HSBC Bank plc
 GBM down $7bn (2%), including $4bn
deposits transferred to CMB
 Average GPS balances of $733bn were
down $15bn vs. 4Q22, partly reflecting
seasonality (down $19bn vs. 1Q22)
 Time deposits are 25% of our Hong Kong
deposit base, up 3ppts vs. 4Q22 (HSBC Hong
Kong: 22%, up 4ppts; Hang Seng Bank: 35%,
up 1ppt)
Balances by entity
$21bn
1%
$23bn
$8bn
$(0)bn
(4)%
$(2)bn
(0)%
$(6)bn
(1)%
$(1)bn
0%
$23bn
9%
$1bn
1%
$1bn
4%
$1bn
2%
Growth since 4Q22
$779bn
$344bn
$102bn
$31bn
$1,604bn
$533bn
$282bn
$27bn
$40bn
Asia (HBAP)
UK RFB (HBUK)
USA (HNAH)
Mexico (HBMX)
HSBC Bank plc
(HBEU)
Other 8
o/w: Hong
Kong
HSBC Middle
East (HBME)
Total
329
837
329
0	1
488
1Q22
784
1,604
468 	471
4Q22
1
810
1,583
322
1Q23
WPB
CMB
GBM
1,655
o/w:
SVB UK
o/w: France
retail
1,666
0
86 	62
1,669
HFS

-- 28 of 37 --

28
Appendix	1Q23 results
Shareholders’
equity, $bn
Tangible equity,
$bn
TNAV per share,
$
Basic number of ordinary
shares, millions
IFRS 4 at 31 December 2022 	187.5 	149.4 	7.57 	19,739
IFRS 17 transition impact 	(9.7) 	(2.5) 	(0.13) 	—
At 31 December 2022 	177.8 	146.9 	7.44 	19,739
Profit attributable to: 	10.7 	10.7 	0.54 	—
Ordinary shareholders 24 	10.3 	10.7 	0.54 	—
Other equity holders 	0.4 	— 	— 	—
Dividends 	(0.4) 	— 	— 	—
On ordinary shares 	— 	— 	— 	—
On other equity instruments 	(0.4) 	— 	— 	—
FX 24 	0.9 	0.8 	0.04 	—
Actuarial gains/(losses) on defined benefit plans 	0.3 	0.3 	0.01 	—
Cash flow hedge reserves 	0.8 	0.8 	0.04 	—
Fair value movements through ‘Other Comprehensive Income’ 	0.6 	0.6 	0.03 	—
Of which: changes in fair value arising from changes in own credit risk 	(0.0) 	(0.0) 	— 	—
Of which: Debt and Equity instruments at fair value through OCI 	0.6 	0.6 	0.03 	—
Other 24 	(0.6) 	(0.6) 	(0.02) 	(3)
At 31 March 2023 	190.1 	159.5 	8.08 	19,736
 Average basic number of shares outstanding during 1Q23: 19,724
 1Q23 TNAV per share increased by $0.64 to $8.08 per share, mainly due to higher profits
$8.01 on a fully diluted
basis
19,903 million on a
fully diluted basis
1Q23 vs. 4Q22 equity drivers

-- 29 of 37 --

29
Appendix	1Q23 results
Total shareholders’ equity to CET1 capital
1Q23 IFRS 17 4Q22 IFRS 17* 	4Q22 IFRS 4
Total equity (per balance sheet) 	197,523 	185,197 	196,028
Non-controlling interests 	(7,428) 	(7,364) 	(8,544)
Total shareholders’ equity 	190,095 	177,833 	187,484
Additional Tier 1 	(19,392) 	(19,746) 	(19,746)
Total ordinary shareholders' equity 	170,703 	158,087 	167,738
Foreseeable dividend 	(8,132) 	(4,436) 	(4,436)
Adjustment for insurance / SPE’s25 	(3) 	(3) 	(3)
Allowable NCI in CET1 	4,192 	4,444 	4,444
CET1 before regulatory adjustments 	166,760 	158,092 	167,743
Prudential valuation adjustment 	(1,147) 	(1,171) 	(1,171)
Intangible assets 	(12,593) 	(12,141) 	(12,141)
Deferred tax asset deduction 	(4,343) 	(4,235) 	(4,235)
Cash flow hedge adjustment 	2,904 	3,601 	3,601
Excess of expected loss 	(1,618) 	(1,248) 	(1,248)
Own credit spread and debit valuation adjustment 	(369) 	(412) 	(412)
Defined benefit pension fund assets 	(5,948) 	(5,448) 	(5,448)
Direct and indirect holdings of CET1 instruments 	(40) 	(40) 	(40)
Other regulatory adjustments to CET1 capital (including
IFRS 9 transitional adjustments when relevant) (720) 	(220) 	(220)
Threshold deductions 	(17,200) 	(17,487) 	(27,138)
Regulatory adjustments 	(41,074) 	(38,801) 	(48,452)
CET1 capital 	125,686 	119,291 	119,291
190,095
CET1 capital
197,523
Allowable NCI in CET1
(7,428)
(3)
Non-controlling interests
Total shareholders’
equity
(19,392)	Additional Tier 1
166,760
Total ordinary
shareholders’ equity
(8,132)
125,686
(41,074)
Foreseeable
dividend
Adjustment of
insurance / SPE’s
4,192
Total equity
CET1 before
regulatory adjustments
Regulatory adjustments
170,703
Total equity to CET1 capital, at 31 March 2023, $m 	Total equity to CET1 capital walk5, $m
* The overall impact of IFRS17 on CET1 capital is nil since its impact on total shareholders’ equity has an offset with threshold deductions

-- 30 of 37 --

30
Appendix	1Q23 results
Reconciliations
$m 	FY22,
IFRS 4
reported
IFRS 17
adjustment
FY22,
IFRS 17
reported
NII 	32,610 	(2,233) 	30,377
Non-NII 	19,117 	1,126 	20,243
Revenue 	51,727 	(1,107) 	50,620
Costs 	(33,330) 	(629) 	(32,701)
PBT 	17,528 	(470) 	17,058
NIM, % 	1.48 	(6)bps 	1.42
AIEA, $bn 	2,204 	(60) 	2,144
FY22 IFRS 4 and IFRS 17	Reconciliation of reported costs to FY23 cost target basis
$m 	1Q23 	1Q22 	FY22
Reported 	7,586 	8,178 	32,701
Currency impact* 	— 	(466) 	(480)
Constant currency 	7,586 	7,712 	32,221
Notable items 	(61) 	(451) 	(2,900)
FX impact on notable items* 	— 	31 	4
Hyperinflation2 	— 	59 	235
SVB UK and related investments 	— 	— 	—
Target basis 	7,525 	7,351 	29,560
* 1Q22 at 1Q23 average FX rates; 2Q22 to 4Q22 at March 2023 average FX rates

-- 31 of 37 --

31
Appendix	1Q23 results
CRE exposures (data as at FY22)
Commercial real estate exposure, $m26
Asia	
o/w HK 	Europe	
o/w UK 	NAM* 	LATAM 	MENA 	Total
Gross loans and
advances 66,433	
50,103 	21,888	
16,044 	5,415 	978 	1,765 	96,479
o/w stage 1 	46,757	
35,963 	17,318	
12,209 	2,109 	880 	1,115 	68,179
o/w stage 2 	16,337	
11,092 	3,590	
3,008 	3,298 	44 	364 	23,633
o/w stage 3 	3,339	
3,048 	980	
827 	8 	54 	286 	4,667
Stage 3 as a % of loans 	5.0	
6.1 	4.5	
5.2 	0.0 	5.5 	16.2 	4.8
 	Exposure in North America of $5.4bn, down 25%
vs. 2020 (4Q20: $7.7bn) as a result of de-risking
actions
 	In more developed markets such as the UK and
Hong Kong, our exposure mainly comprises the
financing of investment assets, the redevelopment
of existing stock and the augmentation of both
commercial and residential markets to support
economic and population growth
 	Hong Kong exposure includes exposure to
mainland China CRE of $9.4bn, which accounts for
$1.7bn of the $3.0bn stage 3 exposure
 	In less developed commercial real estate markets,
our exposures comprise lending for development
assets on relatively short tenors with a particular
focus on supporting larger, better capitalised
developers involved in residential construction or
assets supporting economic expansion
LTV analysis (fully collateralised exposure)27
69%
25%
4%
2%
62%
6% 4%
28%
76-90%
<50%
51-75%
91-100%
Hong Kong 	UK
* CRE in North America (NAM) relates to exposure in the USA and Bermuda only given Canada is classified as held-for-sale. During 1Q23, we aligned the classification of CRE across the Group and re-presented NAM CRE exposure at 4Q22 as $5.4bn
(previously reported as $2.3bn), which has a corresponding ECL charge of $0.1bn

-- 32 of 37 --

32
Appendix	1Q23 results
Supplementary information
The following tables show the results of our Middle East and North Africa
business operations on a regional basis (including results of all the legal entities
operating in the region and our share of the results of Saudi Awwal Bank) and by
global business
Middle East and North Africa	Reported PBT by legal entity, $m
1Q23 	4Q22 	1Q22
HSBC UK Bank plc (HBUK) 	3,131 	1,140 	1,170
HSBC Bank plc (HBEU) 	2,714 	(356) 	(23)
The Hongkong and Shanghai Banking
Corporation Limited (HBAP) 5,849 	3,753 	2,765
HSBC Bank Middle East Limited (HBME) 	377 	179 	182
HSBC North America Holdings Inc. (HNAH) 	307 	84 	310
HSBC Bank Canada (HBCA) 	239 	219 	231
Grupo Financiero HSBC, S.A. de C.V. (HBMX) 	215 	140 	113
Other trading entities8 	493 	438 	262
-
of which: other Middle East entities
(Oman, Türkiye, Egypt, Saudi Arabia)
139	
150	
210
-
of which: Saudi Awwal Bank	
110	
133	
(2)
Holding companies, shared service centres
and intra-group eliminations (439) 	(548) 	(866)
Total 	12,886 	5,049 	4,144
Profit before tax by global business, $m 	1Q23 	4Q22 	1Q22
Wealth and Personal Banking 	141 	91 	48
Commercial Banking 	119 	69 	95
Global Banking and Markets 	296 	201 	268
Corporate Centre 	71 	98 	(25)
Total 	627 	459 	386
Regional performance, $m 	1Q23 	4Q22 	1Q22
Revenue 	899 	810 	724
ECL 	(8) 	(35) 	43
Operating expenses 	(374) 	(449) 	(380)
Share of profit/(loss) from associates and joint
ventures 110 	133 	(2)
Profit before tax 	627 	459 	385
Loans and advances to customers (net) 	25,160 	26,475 	26,708
Customer accounts 	45,830 	43,933 	43,873

-- 33 of 37 --

33
Appendix	1Q23 results
Glossary
AGM 	Annual General Meeting
AIEA 	Average interest earning assets
ANP 	Annualised new business premiums
AT1 	Additional Tier 1
BoCom 	Bank of Communications Co. Limited, an associate of HSBC
Bps 	Basis points. One basis point is equal to one-hundredth of a percentage point
CET1 	Common Equity Tier 1
Corporate Centre
(CC)
Corporate Centre comprises Central Treasury, our legacy businesses, interests in our associates
and joint ventures and central stewardship costs
CMB 	Commercial Banking, a global business
CSM
Contractual Service Margin, a component of the carrying amount of a group of insurance
contract assets or liabilities which represents the unearned profit which the Group will recognise
as it provides insurance contract services under the insurance contracts in the Group
CRE 	Commercial Real Estate
CTA 	Costs to achieve
DPS 	Dividend per share
ECL
Expected credit losses. In the income statement, ECL is recorded as a change in expected credit
losses and other credit impairment charges. In the balance sheet, ECL is recorded as an
allowance for financial instruments to which only the impairment requirements in IFRS 9 are
applied
EPS 	Earnings per share
GBM 	Global Banking and Markets, a global business
GPS 	Global Payments Solutions (formerly GLCM: Global Liquidity and Cash Management)
Group 	HSBC Holdings plc and its subsidiary undertakings
GTRF 	Global Trade and Receivables Finance
HFS 	Held-for-sale
HQLA 	High-quality liquid assets
HTC&S 	Hold to collect and sell
IFRS 	International Financial Reporting Standard
IFRS 4 	IFRS 4 ‘Insurance Contracts’
IFRS 17 	IFRS 17 ‘Insurance Contracts’
LTV 	Loan to value
MENA 	Middle East and North Africa, including Türkiye
MSS 	Markets and Securities Services
NAV 	Net asset value
NBFI 	Non-bank financial institution
NCI 	Non-controlling interests
NIM 	Net interest margin
NNIA 	Net new invested assets
OCI 	Other Comprehensive Income
PAOS 	Profit attributable to ordinary shareholders
PBT 	Profit before tax
Ppt 	Percentage points
PRP 	Performance related pay
SAB 	Saudi Awwal Bank, an associate of HSBC
SEA 	Southeast Asia, includes Indonesia, Malaysia, Philippines, Singapore, Thailand and Vietnam
SPE 	Special purpose entity
SVB UK 	Silicon Valley Bank UK
RoTE 	Return on average tangible equity
RWA 	Risk-weighted asset
T&E 	Travel and entertainment
TMD 	Time deposits
TNAV 	Tangible net asset value
UK RFB / RFB 	HSBC UK, the UK ring-fenced bank, established July 2018 as part of ring fenced bank legislation
WPB 	Wealth and Personal Banking, a global business
XVAs 	Credit and Funding Valuation Adjustments

-- 34 of 37 --

34
Appendix	1Q23 results
Footnotes
1. 	Report on Transition to IFRS 17 ‘Insurance Contracts’, available at www.hsbc.com/investors
2. 	The impact of retranslating the 2022 results of hyperinflationary economies at constant currency
3. 	RoTE on an annualised basis
4. 	Subject to approval of the relevant resolutions. Contractual term of 5 months expected
5. 	Unless otherwise stated, regulatory capital ratios and requirements are on a reported basis, and are
based on the transitional arrangements of the Capital Requirements Regulation in force at the time.
Leverage metrics exclude central bank claims in accordance with the Prudential Regulation
Authority's (‘PRA‘) UK leverage framework. References to EU regulations and directives (including
technical standards) should, as applicable, be read as references to the UK‘s version of such
regulation or directive, as onshored into UK law under the European Union (Withdrawal) Act 2018,
and as may be subsequently amended under UK law
6. 	Numbers shown on a reported basis. When currency-adjusted, 4Q22 figure is $(1.4)bn and all other
periods are unchanged
7. 	Includes held-for-sale balances
8. 	Including "of which Other Middle East Entities (Oman, Turkiye, Egypt and Saudi Arabia)" and "of
which SAB“ which do not consolidate into HSBC Bank Middle East Limited
9. 	1Q22 at 1Q23 average FX rates; 2Q22 to 4Q22 at March 2023 average FX rates
10. Excluding holdings for our insurance business which have been primarily reclassified out of HTC
under IFRS 17
11. The CET1 ratio itemised movement presented on the graph includes the impact of threshold
deductions, whereas the CET1 movement break-down in $bn excludes the impact of threshold
deductions
12. Regulatory profits
13. Includes ordinary dividend accrual of $3.5bn and AT1 coupon payment of $0.4bn
14. Based on tangible equity (‘TE’) of the Group’s major legal entities excluding associates, holding
companies and consolidation adjustments. Asia refers to The Hongkong and Shanghai Banking
Corporation (HBAP)
15. Medium term is defined as 3-4 years from 1 January 2020; long term is defined as 5-6 years from 1
January 2020
16. In determining our dividend payout ratio we will exclude material notable items (including the
planned sale of our banking business in Canada) from reported earnings per share
17. RoTE methodology annualises Profits Attributable to Shareholders, including ECL, in order to
provide a returns metric. RoTE by Global Business considers AT1 Coupons on an accruals basis, vs.
Reported RoTE where it is treated on a cash basis
18. Included within held for sale at 4Q22 were balances associated our retail banking operations in
France and our banking business in Canada. In 1Q23 held for sale balances related to our banking
business in Canada only
19. Wealth deposits include Premier, Jade and Global Private Banking deposits, which include Prestige
deposits in Hang Seng Bank, and form part of the total WPB customer accounts balance
20. Included within held for sale are balances associated with our banking business in Canada
21. Includes revenue shared with Markets and Securities Services and CMB
22. Customer lending shown is as reported in loans and advances to external customers and does not
include lending to financial institutions
23. After initial deposit outflows following our acquisition of SVB UK, deposits are now stabilising and
client exits have been minimal
24. Differences between shareholders’ equity and tangible equity drivers primarily reflect goodwill and
other intangible impairment and amortisation expense within ‘Profit Attributable to Ordinary
shareholders’, FX on goodwill and intangibles within ‘FX’, and intangible additions and other
movements within ‘Other’
25. A revised approach to insurance-related adjustments has been effective from 30 September 2022.
This has had no impact on overall CET1 capital
26. Based on the loan purpose for on balance sheet exposures only
27. Based on the industry sector of the obligor / borrower including both on and off balance sheet
exposures. Totals for Hong Kong $36.2bn, UK $12.7bn

-- 35 of 37 --

35
Appendix	1Q23 results
Disclaimer
Important notice
The information, statements and opinions set out in this presentation and accompanying discussion (this “Presentation”) are for informational and reference purposes only and do not constitute a public offer for the purposes of any
applicable law or an offer to sell or solicitation of any offer to purchase any securities or other financial instruments or any advice or recommendation in respect of such securities or other financial instruments.
This Presentation, which does not purport to be comprehensive nor render any form of legal, tax, investment, accounting, financial or other advice, has been provided by HSBC Holdings plc (together with its consolidated subsidiaries,
the “Group”) and has not been independently verified by any person. You should consult your own advisers as to legal, tax investment, accounting, financial or other related matters concerning any investment in any securities. No
responsibility, liability or obligation (whether in tort, contract or otherwise) is accepted by the Group or any member of the Group or any of their affiliates or any of its or their officers, employees, agents or advisers (each an “Identified
Person”) as to or in relation to this Presentation (including the accuracy, completeness or sufficiency thereof) or any other written or oral information made available or any errors contained therein or omissions therefrom, and any such
liability is expressly disclaimed.
No representations or warranties, express or implied, are given by any Identified Person as to, and no reliance should be placed on, the accuracy or completeness of any information contained in this Presentation, any other written or
oral information provided in connection therewith or any data which such information generates. No Identified Person undertakes, or is under any obligation, to provide the recipient with access to any additional information, to update,
revise or supplement this Presentation or any additional information or to remedy any inaccuracies in or omissions from this Presentation. Past performance is not necessarily indicative of future results. Differences between past
performance and actual results may be material and adverse.
Forward-looking statements
This Presentation may contain projections, estimates, forecasts, targets, opinions, prospects, results, returns and forward-looking statements with respect to the financial condition, results of operations, capital position, strategy and
business of the Group which can be identified by the use of forward-looking terminology such as “may”, “will”, “should”, “expect”, “anticipate”, “project”, “plan”, “estimate”, “seek”, “intend”, “target”, “believe”, "potential" and
"reasonably possible" or the negatives thereof or other variations thereon or comparable terminology (together, “forward-looking statements”), including the strategic priorities and any financial, investment and capital targets and any
ESG related targets, commitments and ambitions described herein. Any such forward-looking statements are not a reliable indicator of future performance, as they may involve significant stated or implied assumptions and subjective
judgements which may or may not prove to be correct. There can be no assurance that any of the matters set out in forward-looking statements are attainable, will actually occur or will be realised or are complete or accurate. The
assumptions and judgments may prove to be incorrect and involve known and unknown risks, uncertainties, contingencies and other important factors, many of which are outside the control of the Group. Actual achievements,
results, performance or other future events or conditions may differ materially from those stated, implied and/or reflected in any forward-looking statements due to a variety of risks, uncertainties and other factors (including without
limitation those which are referable to general market or economic conditions, regulatory changes, increased volatility in the financial services and banking sector, geopolitical tensions such as the Russia-Ukraine war, the impact of the
Covid-19 pandemic or as a result of data limitations and changes in applicable methodologies in relation to ESG related matters). Any such forward-looking statements are based on the beliefs, expectations and opinions of the Group
at the date the statements are made, and the Group does not assume, and hereby disclaims, any obligation or duty to update, revise or supplement them if circumstances or management’s beliefs, expectations or opinions should
change. For these reasons, recipients should not place reliance on, and are cautioned about relying on, any forward-looking statements. No representations or warranties, expressed or implied, are given by or on behalf of the Group as
to the achievement or reasonableness of any projections, estimates, forecasts, targets, commitments, ambitions, prospects or returns contained herein.
Additional detailed information concerning important factors, including but not limited to ESG related factors, that could cause actual results to differ materially from this Presentation is available in our Annual Report and Accounts for
the fiscal year ended 31 December 2022 filed with the Securities and Exchange Commission (the “SEC”) on Form 20-F on 22 February 2023 (the “2022 Form 20-F”) and our 1Q 2023 Earnings Release which we expect to furnish with
the SEC on Form 6-K on 2 May 2023 (the “1Q 2023 Earnings Release”).
Alternative Performance Measures
This Presentation contains non-IFRS measures used by management internally that constitute alternative performance measures under European Securities and Markets Authority guidance and non-GAAP financial measures defined in
and presented in accordance with SEC rules and regulations (“Alternative Performance Measures”). The primary Alternative Performance Measures we use are presented on a “constant currency” basis which is computed by
adjusting comparative period reported results for the effects of foreign currency translation differences, which distort period-on-period comparisons.
Reconciliations between Alternative Performance Measures and the most directly comparable measures under IFRS are provided in our 1Q 2023 Earnings Release, when filed, which is available at www.hsbc.com.
Information in this Presentation was prepared as at 2 May 2023.

-- 36 of 37 --



-- 37 of 37 --